DE68903516D1 - Mittel zur senkung des blutdrucks. - Google Patents

Mittel zur senkung des blutdrucks.

Info

Publication number
DE68903516D1
DE68903516D1 DE8989200661T DE68903516T DE68903516D1 DE 68903516 D1 DE68903516 D1 DE 68903516D1 DE 8989200661 T DE8989200661 T DE 8989200661T DE 68903516 T DE68903516 T DE 68903516T DE 68903516 D1 DE68903516 D1 DE 68903516D1
Authority
DE
Germany
Prior art keywords
agent
blood pressure
reducing blood
reducing
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989200661T
Other languages
English (en)
Other versions
DE68903516C5 (de
DE68903516T2 (de
Inventor
Raymond Mathieu Xhonneux
Lommen Guy Rosalia Eugene Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629045&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68903516(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE68903516D1 publication Critical patent/DE68903516D1/de
Application granted granted Critical
Publication of DE68903516T2 publication Critical patent/DE68903516T2/de
Anticipated expiration legal-status Critical
Publication of DE68903516C5 publication Critical patent/DE68903516C5/de
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
DE68903516.0T 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks. Expired - Lifetime DE68903516C5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17274788A 1988-03-23 1988-03-23
US172747 1988-03-23

Publications (3)

Publication Number Publication Date
DE68903516D1 true DE68903516D1 (de) 1992-12-24
DE68903516T2 DE68903516T2 (de) 1993-04-01
DE68903516C5 DE68903516C5 (de) 2017-07-13

Family

ID=22629045

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1996175037 Pending DE19675037I1 (de) 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks
DE68903516.0T Expired - Lifetime DE68903516C5 (de) 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1996175037 Pending DE19675037I1 (de) 1988-03-23 1989-03-16 Mittel zur Senkung des Blutdrucks

Country Status (19)

Country Link
EP (1) EP0334429B1 (de)
JP (1) JPH0637487B2 (de)
KR (1) KR970011287B1 (de)
AU (1) AU621591B2 (de)
CA (1) CA1337432C (de)
CY (1) CY1802A (de)
DE (2) DE19675037I1 (de)
DK (1) DK174422B1 (de)
ES (1) ES2052881T3 (de)
GR (1) GR3006972T3 (de)
HK (1) HK123594A (de)
HU (1) HU211539A9 (de)
IE (1) IE62159B1 (de)
IL (1) IL89691A (de)
LU (1) LU88842I2 (de)
NL (1) NL950031I2 (de)
NZ (1) NZ228321A (de)
PT (1) PT90095B (de)
ZA (1) ZA892179B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
HU226208B1 (en) * 1994-12-28 2008-06-30 Janssen Pharmaceutica Nv Use of nebivolol for producing anti-atherogenic pharmaceuticals
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
US5670667A (en) * 1995-07-25 1997-09-23 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US7417038B1 (en) 1998-10-15 2008-08-26 Imperial Innovations Limited Methods of treating cachexia
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
RU2378272C2 (ru) 2004-07-30 2010-01-10 Торрент Фармасьютикалз Лимитед Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола
US20070021623A1 (en) * 2004-08-11 2007-01-25 Hetero Drugs Limited Novel process for preparation of nebivolol intermediates
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
EP1848424B1 (de) * 2005-01-31 2017-04-05 Mylan Laboratories, Inc Pharmazeutische zusammensetzung enthaltend hydroxyliertes nebivolol
WO2006083780A2 (en) * 2005-01-31 2006-08-10 Mylan Laboratories, Inc. Glucuronidated nebivolol
CN100546987C (zh) * 2005-03-03 2009-10-07 浙江医药股份有限公司新昌制药厂 Dl-奈必洛尔及其盐酸盐的制备方法
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (de) * 2005-12-28 2012-07-25 Acino Pharma AG Ein Verfahren zur Herstellung von racemischem Nebivolol
WO2007083318A1 (en) 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
BRPI0719367B8 (pt) * 2006-11-27 2021-05-25 Fis Fabbrica Italiana Sintetici Spa processo para a preparação de nebivolol, seus intermediários e usos
CA2667919C (en) * 2006-11-27 2014-10-28 Zach System S.P.A. Process for preparing nebivolol
GB0624282D0 (en) 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
WO2008089549A1 (en) 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
CN101531651B (zh) * 2008-03-13 2011-05-04 四川大学 光学活性3,4-二氢-2h-1-苯并吡喃-2-羧酸和3,4-二氢-4-氧-2h-1-苯并吡喃-2-羧酸类化合物的制备方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
US8785664B2 (en) 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) * 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
WO2014111903A2 (en) 2013-01-21 2014-07-24 Cadila Pharmaceuticals Limited A process for the preparation of 6-fluoro-3,4-dihydro-2h-chromene- 2-carbaldehyde
ES2700973T3 (es) 2014-02-14 2019-02-20 Corden Pharma Int Gmbh Proceso sin base para la preparación de compuestos intermedios de cetona que se pueden usar para fabricar nebivolol
EP2907810A1 (de) 2014-02-14 2015-08-19 Corden Pharma International GmbH Neues Verfahren zur Herstellung von hochreinem Nebivolol-Hydrochlorid
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
US10526304B2 (en) 2015-05-19 2020-01-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Nebivolol synthesis method and intermediate compound thereof
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol

Also Published As

Publication number Publication date
IE890906L (en) 1989-09-23
JPH01283220A (ja) 1989-11-14
AU3074289A (en) 1989-09-28
ES2052881T3 (es) 1994-07-16
CY1802A (en) 1995-02-17
IE62159B1 (en) 1994-12-28
DK146289D0 (da) 1989-03-22
GR3006972T3 (de) 1993-06-30
DE68903516C5 (de) 2017-07-13
NL950031I2 (nl) 1997-01-06
LU88842I2 (fr) 1997-01-27
NZ228321A (en) 1991-02-26
HK123594A (en) 1994-11-18
EP0334429A1 (de) 1989-09-27
JPH0637487B2 (ja) 1994-05-18
CA1337432C (en) 1995-10-24
IL89691A (en) 1994-04-12
KR890014510A (ko) 1989-10-24
AU621591B2 (en) 1992-03-19
DK146289A (da) 1989-09-24
PT90095B (pt) 1994-11-30
EP0334429B1 (de) 1992-11-19
NL950031I1 (de) 1996-02-01
DE68903516T2 (de) 1993-04-01
KR970011287B1 (ko) 1997-07-09
ZA892179B (en) 1990-11-28
DE19675037I1 (de) 2003-09-04
PT90095A (pt) 1989-11-10
HU211539A9 (en) 1995-12-28
IL89691A0 (en) 1989-09-28
DK174422B1 (da) 2003-02-24

Similar Documents

Publication Publication Date Title
DE68903516D1 (de) Mittel zur senkung des blutdrucks.
DE3861517D1 (de) Blutdruckueberwacher.
NO905431L (no) Trykkapplikator for medikament.
DE3787725D1 (de) Blutdruckregelungssystem.
DE69003970D1 (de) System zur Blutkonservierung.
NO901158L (no) Blodtrykk-overvaakningskateter.
DE3883171D1 (de) Druckempfindliches medizinisches dichtungsmittel.
DE68902353D1 (de) Hautdepigmentierungsmittel.
DE68909242D1 (de) Adhäsives mittel zur arzneistoffabgabe.
DE3781569D1 (de) Mittel zur oralen verwendung.
DE68918202D1 (de) Blutdruck-Messsystem.
DE3776002D1 (de) Blutdruckmessmanschette.
DE68909970D1 (de) Hautbehandlungsmittel.
DE69424252D1 (de) Blutdrucküberwachungssystem
DE68914495D1 (de) Antihypercholesterolemisches Mittel.
EP0678557A3 (de) Blutverträgliche, scheer-sensitive Gele.
DE69529947D1 (de) Blutdruck-Überwachungsgerät
DE3850869D1 (de) Blutdruck-Messgerät.
DE3863159D1 (de) Blutdruckmanschettenhalterung.
DE69003598D1 (de) Melanogenese-inhibitierendes mittel zur aeusserlichen anwendung.
DE68910100D1 (de) Mittel zur Bluttrennung.
DE3860754D1 (de) Blutdruckmonitor und dafuer verwendeter pneumatischer verbinder.
DE3769843D1 (de) Mittel zur verhinderung von krustungsbildung.
DE3681476D1 (de) Mittel zur verbesserung der lebensfunktion und mittel zur senkung des blutdrucks.
DE3885468D1 (de) Mittel zur verringerung des lipidperoxidgehaltes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition